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Abstract
Background: A fast-track intervention with a short preoperative optimization period and short postoperative
hospitalization has a potential for reduced convalescence and thereby a reduced need for postoperative
rehabilitation. The purpose of this study was to describe patient-related outcomes, the need for additional
rehabilitation after a fast-track total hip arthroplasty (THA), and the association between generic and disease
specific outcomes.
Methods: The study consisted of 196 consecutive patients of which none received additional rehabilitation
beyond an instructional exercise plan at discharge, which was adjusted at one in-patient visit. The patients filled in
3 questionnaires to measure health-related quality-of-life (HRQOL) and hip specific function (EQ-5 D, SF36, and
Harris Hip Score (HHS)) at 2 time points pre- and 2 time points postoperatively. The observed results were
compared to normative population data for EQ-5 D, SF36, and HHS.
Results: 3-months postoperatively patients had reached a HRQOL level of 0.84 (SD, 0.14), which was similar to the
population norm (P = 0.33), whereas they exceeded the population norm at 12 months postoperatively (P < 0.01).
For SF36, physical function (PF) was 67.8 (SD, 19.1) 3 months postoperatively, which was lower than the population
norm (P < 0.01). PF was similar to population norm 12-months postoperatively (P = 0.35). For HHS, patients never
reached the population norm within 12 months postoperatively. Generic and disease specific outcomes were
strongly associated.
Conclusions: If HRQOL is considered the primary outcome after THA, the need for additional postoperative
rehabilitation for all THA patients following a fast-track intervention is questionable. However, a pre- or early
postoperative physical intervention seems relevant if the PF of the population norm should be reached at 3
months. If disease specific outcome is considered the primary outcome after fast-track THA, clear goals for the
rehabilitation must be established before patient selection, intervention type and timing of intervention can be
made.
Background
The purpose of a patient receiving THA is to reduce
pain and regain health, and WHO proposes to focus on
health-related quality-of-life (HRQOL) in the “bone and
joint decade” (2000-2010), when monitoring the effect
of health care interventions [1]. Therefore the ultimate
goal for THA must be to regain HRQOL comparable to
the age and gender specific population. Normative data
for HRQOL by using generic instruments exist for the
questionnaires EuroQOL (EQ-5D) [2,3] and The Medi-
cal Outcome Study 36-item Short-Form Health Survey
(SF36) [4] which are proven to be useful and validated
tools [5-8]. Likewise, reference values from disease spe-
cific instruments such as Western Ontario and McMas-
ter Universities Osteoarthritis Index (WOMAC) score
and Harris Hip Score (HHS) are available [9], useful and
validated tools [6,10-12]. Using EQ-5 D as the reference
outcome for HRQOL, the age and gender matched
population will show a very small average decrease of
0.01 point in HRQOL from the age of 65 to 70 [2]. In
contrast, the THA patient will show a steady and large
decrease in HRQOL from onset of hip pain until refer-
ral, where the average HRQOL is 0.47 [13]. In a
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waiting time from referral until operation, during which
their HRQOL will continue the decline [14], and the
patient may not reach the population level for HRQOL
within the first year [15].
In Denmark approximately 7.000 primary elective total
hip arthroplasties (THA) were performed in 30 public
hospitals in 2007 [16]. Of these hospitals only 2 (7%)
used a “fast-track” intervention defined as preoperative
optimization of ≤ 8 weeks or waiting time ≤ 4w e e k s ,a
perioperative intervention reaching discharge criteria ≤
4 days, and a postoperative intervention focused on
information of restrictions and instructions in home
exercises in order to achieve normal daily functions as
soon as possible in order to reach a health-related qual-
ity-of-life (HRQOL) at the population level ≤ 3m o n t h s
postoperatively [16]. In a fast-track context the popula-
tion level of HRQOL should be achieved as fast as pos-
sible and with as less pain and risk of complications as
possible [17,18]. In the study by Larsen et al. [15] THA
patients who followed an fast-track intervention reached
the age and gender specific HRQOL level of 0.87 at 12
weeks postoperatively. The perioperative intervention
followed the general fast-track regimen proposed by
Kehlet et al. [17,18], and the THA specific regimen pro-
posed by Husted et al., and Larsen et al. [13,18-22]. The
postoperative intervention focused on information of
restrictions and instructions in home exercises in order
to achieve normal daily functions as soon as possible.
The purpose of this study was to describe patient-
related functional outcomes after fast-track THA, the
need for additional rehabilitation, and to describe the
associations between generic and disease specific
outcomes.
Methods
The study group consisted of consecutive patients fulfill-
ing inclusion criteria for case mix group, who were
operated on at the Regional Hospital Holstebro in 2007
and then followed for 12 months postoperatively. The
case mix group inclusion criteria were age at or above
55 years and a diagnosis of primary arthrosis. Patients
with bilateral disease who were operated on the bilateral
hip during the following 12 months were excluded.
The procedures followed in this study were in accor-
dance with the Helsinki Declaration of 1975, as revised
in 2000. The study was generally approved by the local
research ethics committee, and no further specific
approval was demanded because the study is an out-
come study, which according to the Danish law “Act on
a Biomedical Research Ethics Committee System and
the Processing of Biomedical Research Projects”,P a r t3
“Notification and authorization”: Questionnaire-based
projects and register research projects shall only be
notified to a regional committee if the project also
involves human biological material. The study was regis-
tered in The Danish data Protection Agency (j.nr. 2007-
41-1197).
Fast-track intervention
Preoperatively
All included patients followed a preoperative optimiza-
tion regimen, where patients were screened by a nurse
on the day of diagnosis using a preoperative arthroplasty
screening questionnaire (PASQ) consisting of five areas:
1) nutrition, 2) general health and medication, 3) physi-
cal activity, 4) smoking habits, and 5) alcohol consump-
tion. The data for PASQ are derived from 2 sources, a
mailed questionnaire and a structured interview
included in a motivational conversation. The nurse pro-
posed an intervention plan for all patients with identi-
fied risk factors. All patients, accompanied by one
relative, were invited to an information and preparation
day one week before surgery. The purpose of the infor-
mation day was to introduce the patients to team staff
members, to inform the patients about the fast-track
protocol, and to give individual consultation with sur-
geon, anesthetist, and nurse. The patients were informed
about the goals during the hospital stay with intended
reach of discharge criteria within 4 nights postopera-
tively. In addition they were taught pain relief modal-
ities, mobilization strategies, and instruction in use of
walking aids.
Perioperatively
Surgery All surgery took place in the beginning of the
week. Five experienced surgeons performed all opera-
tions. Templating was used for implant size. Patients
had surgical and anesthetic procedures that followed
Danish guidelines of which one is use of cemented
implants in THA patients above 70 years of age [23].
We used a medium size posterior incision and a pero-
perative local infiltration analgesia (LIA) consisting of
100 ml of ropivacaine (Naropin® 2 mg/ml), 1 ml ketoro-
lac (Toradol®) (30 mg/ml), 0.5 ml adrenaline (1 mg/ml)
[24]. Drains were not used. Blood transfusion was stan-
dardized, and for antithrombotic prophylaxis we used
Arixtra® (Fondaparinux). To prevent infections we used
Diclosil® (dicloxacilline) 1 g preoperatively and 3 times
postoperatively during the first 24 hours after surgery.
Care in specialized ward The patients were hospita-
lized in the nurse-led fast-track care unit, which was
placed in a separate part of the ward. One nurse was in
charge of a team of healthcare professionals who were
trained to initiate mobilization activities aggressively.
Patients were asked to wear their own clothes during
the entire hospital stay to avoid a sense of sickness or
dependency, and mobilized in teams. The staff and
patients followed daily preset written goals regarding: 1)
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nutrition, 5) mobilization, and 6) bowel regulation.
Mobilization started on the day of surgery. On the first
postoperative day, the goal was to be out of bed 4
hours, including training with physiotherapist and occu-
pational therapist and 8 hours of mobilization/day for
the rest of the hospital stay. Detailed description of the
accelerated protocol has been published before
[13,15,21,22].
Mobilization Physiotherapy and occupational therapy
was given once daily on weekdays. Mobilization con-
sisted of all activities out of bed (70% of mobilization
time), gait training (15% of mobilization time), and exer-
cises (15% of mobilization time). The physiotherapist
was responsible for coaching the patient during exer-
cises and gait training. Exercises focused on strengthen-
ing hip and knee muscles and how to avoid restricted
movements. When performing exercises there was
much focus on intensity, number of repetitions and pro-
gression. The patients were taught how to increase exer-
cise and gait training after discharge. The occupational
therapist was responsible for instruction regarding per-
formance of personal needs for the THA patients. All
patients were given an instructional exercise plan at dis-
charge, which was presented and used at the preopera-
tive information day and during hospitalization.
Pain relief Preoperatively, paracetamol 1 g was given 2-
3 hours before the operation. Intraoperatively, we infil-
trated 100 mL ropivacaine 2 mg/mL (Naropine) with 1
mL ketorolac 30 mg/mL (Toradol) and 0.5 mL epi-
nephrine 1 mg/mL (adrenaline) Postoperatively, a bolus
in the wound catheter was given 8 hours postoperatively
consisting of 20 ml of Naropin® (7.5 mg/ml), 1 ml Tora-
dol® (30 mg/ml), 0.5 ml adrenaline (1 mg/ml) [24]. On
the day of operation and the first day postoperatively we
used paracetamol 1g 4 times per day, and Oxycontin®
(oxycodon) (10 mg 2 times daily for patients < 70 years,
and 20 mg 2 times daily for ≥ 70 years of age) and if
V A S>3a tr e s ta n d / o r> 5a tm o b i l i z a t i o nO x y n o r m ®
(oxycodon) 5 mg was given on request. From the second
postoperative day, we used paracetamol 1g 4 times per
day, Mandolgin® (Tramodol) 50-100 mg 2 times per day
and Oxynorm® (Oxycodon) 5 mg if VAS > 3 at rest and/
or >5 at mobilization.
Discharge criteria All patients were discharged to
home. The discharge criteria were: Absence of any signs
of wound problems; satisfactory pain control on oral
analgesics; aware of procedures for safely ending medi-
cation; knowledge of restrictions; being able to walk
safely with or without walking aids; ability to walk up
and down stairs; ability to perform home exercises;
knowing how to increase home exercises; being able to
perform personal care; acceptance of discharge.
Postoperatively
Restrictions To avoid dislocation of the hip prosthesis
patients were told to avoid flexion of the hip joint
beyond 90°, and adduction and internal rotation during
the first 3 months. Patients were also taught which posi-
tions and activities which could be potentially harmful
for the prosthesis.
Intervention In the postoperative intervention period,
the patients were invited to an in-patient visit 7 weeks
postoperatively, where their status was analyzed and
their instructional exercise plan adjusted. No further
rehabilitation was made.
Outcome measures
As part of daily monitoring of outcome for all THA
patients operated on at the Hospital Unit West, Den-
mark, all patients filled in 3 questionnaires (EQ-5 D,
S F 3 6 ,a n dH H S )a t4t i m ep o i n t s( preoperatively at day
of diagnosis, preoperatively at the information day, post-
operatively at 3-months and at 12-months follow-up).
EQ-5 D and SF36 is available in translated and validated
Danish versions [2,4]. The HHS questionnaire we used
was the self-report HHS (SRHHS) developed by
M a h o m e de ta l .[ 2 5 ] .S R H H Si sa7 - i t e mq u e s t i o n n a i r e
using the pain and disability items from the original 15-
item HHS. The Danish version of SRHHS was translated
from English to Danish in respect to the question intro-
duction for the 7 items, and we used the same order of
questions, as was reported in the original study by
Mahomed et al. [25]. We, however, used the Danish
answer categories, which is used in the Danish version
of HHS by the Danish Hip Arthroplasty Register http://
www.dhr.dk/HofteskemaA2008-pdf/Holstebro.pdf.
Statistics
The observed results for the 3 questionnaires were com-
pared with normative population data for EQ-5 D, SF-
36 and HHS. Normative data for HRQOL by using EQ-
5 D were calculated from Sørensen et al. from our
observed gender and age data combined with their
reported HRQOL data for gender and age groups [3].
Normative data for HRQOL in 8 dimensions with SF 36
were likewise estimated from our observed gender and
age data combined with their reported HRQOL data for
gender and age groups in Danish Manual for SF36 [4].
A clinically relevant difference in HRQOL score was set
at 3 percent point [26]. Primary relevant dimension to
encounter the need for additional postoperative rehabili-
tation was the dimension of physical function (PF) in
SF36. The norm data for HHS were obtained using a
modified version of HHS (MHHS) by Lieberman et al.
where the patients were given no impairment, and the
total scores in MHHS were rescaled to 100 points as
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rescaled to 100 points for the best score in order to
compare the results from two HHS outcome measures
[25].
EQ-5 D, PF score in SF36, and HHS at baseline were
grouped into high and low score by dividing them at
the median score in order to investigate if preoperative
score influenced on postoperative HRQOL and physical
function at follow-up. Differences between observed
score and population score were tested with one-sample
t test or two-sample t test. Significance level was set at
P < 0.05.
To test the association between HHS and HRQOL
(EQ-5 D and PF) at 3 and 12-months follow-up we used
Spearman’s correlation and linear regression of the con-
tinuous variables together with multivariate regression
by stepwise model building [27]. The 7 items in HHS
were dichotomized in a clinically meaningful way. Item
1 was dichotomized at no or mild pain against worse.
Item 2 was dichotomized at no cane, or cane for long
walks against other answer categories. Item 3 was
dichotomized at no or slight limping against moderate
or severe limping. Item 4 was dichotomized at walking
&8805; 1.5 km against less. Item 5 was dichotomized at
climbing stairs normally or by need of banister or cane
against other answer categories. Item 6 was dichoto-
mized at can easily put on socks and shoes against can
with difficulty or cannot. Finally, item 7 was dichoto-
mized at to sit comfortably in any chair against other
answer categories. Step one in the multivariate analysis
was a univariate analysis of all variables. Any variable
that had a P-value of < 0.25 was a candidate for the
multivariable model. Step two was a multivariate analy-
sis including all selected candidates. Step three was
exclusion of non-contributing variables, and fitting of
new models without these non-contributing variables.
The variables were excluded one at a time with the vari-
able with the highest P-value first, until only variables
with a P-values of P <0 . 0 5r e m a i n e di nt h em o d e l .
After inspection of the residuals in the preliminary final
model of the multivariate linear regression and if sign of
no misfit it was then considered to be the final model,
which was estimated by using R
2.
Results
Patient sample
A total of 234 patients were eligible for the study, 38
(16%) patients did not meet the inclusion criteria, leav-
ing 196 (84%) patients in the inter-hospital case mix to
be included in the study of which 107 (55%) were men
with a mean age of 70 yrs (SD 8.3), and 112 (57%)
received an un-cemented implant.
The average preoperative optimization period was 46
days (SD, 33). The average hospitalization period was
3.3 days (SD, 2.0), not including 1 patient who was hos-
pitalized 39 days due to complications. A total of 167 of
196 (85%) completed the 3-months follow-up question-
naire. A total of 151 of 196 (77%) completed the 12-
months questionnaire. Only 9 of 196 (5%) patients did
not complete any of the two follow-up questionnaires.
No clinically relevant or significant differences were
observed between patients who responded to the two
follow-up periods, and patients who were lost to follow-
up for age (P ≥ 0.31), gender (P &8805; 0.22), implant
type (P ≥ 0.15), or optimization period (P ≥ 0.12).
Health-related quality-of-life
The age and gender matched population mean HRQOL
estimated by using EQ-5 D was 0.85. The mean
HRQOL for the patient sample preoperatively at time of
diagnosis was 0.56 (SD, 0.23), significantly lower than
the mean HRQOL preoperatively at the information day
0.59 (SD, 0.23) (P < 0.01).
At the 3-months follow-up HRQOL had raised to 0.84
(SD, 0.14), which was not different from the population
norm (P = 0.33). For the group with low (≤ 0.69)
HRQOL at time of diagnosis, HRQOL was 0.82 (SD,
0.14), which was not different than the population norm
(P = 0.06). For the group with high preoperative
HRQOL, HRQOL was 0.86 (SD, 0.13), again not differ-
ent from the population norm (P = 0.59) (Figure 1).
At the 12-months follow-up HRQOL exceeded the
population norm with 0.90 (SD, 0.14) (P < 0.01). The
group with low preoperative score had raised its average
HRQOL to 0.88 (SD, 0.15), not different from the popu-
lation norm (P = 0.12), whereas the group with a high
preoperative score had an HRQOL of 0.92 (SD, 0.14),
which was higher than the population norm (P < 0.01)
Figure 1.
By using SF36, the age and gender matched mean
population norm score for PF was 73.0. The age and
gender specific population norm for all eight dimensions
in SF36 is presented in Figure 2. The average PF for the
patient sample preoperatively at time of diagnosis was
36.8 (SD, 20.6), preoperatively at the information day it
was 39.0 (SD, 20.5) (P = 0.054 between time points).
At the 3-months follow-up the THA patients had
reached the age and gender matched population norm
for 5 of the 8 dimensions (bodily pain, vitality, general
health, social functioning, and mental health) in SF36
(Figure 2). For PF we observed a mean value of 67.8
(SD, 19.1), which was lower than the population norm
of 73.0 (P < 0.001). The observed score for role limita-
tion due to emotional problems (RE) for the sample of
65.0 (SD, 41.3) was also lower (P <0 . 0 0 1 )t h a nt h e
population norm of 76.7. Likewise, the observed score
for role limitation due to physical functioning (RP) of
42.3 (SD, 39.9) was lower than the population nom of
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patient sample with low preoperative physical function
(≤ 35) PF was 64.3 (SD, 19.2) (P < 0.001), and the sam-
ple with high preoperative score PF was 71.8 (P = 0.97).
At the 12-months follow-up the patients had reached
a level at or above the population norm for all 8 dimen-
sions in SF36. (RP with a mean score of 60.3 (SD, 42.6)
(P = 0.26)) (Figure 2). For the patient sample with low
preoperative physical function score (≤ 35) PF was 70.1
(SD, 21.6) at 12-months follow-up, which was not differ-
ent from the population norm (P = 0.25).
Disease specific outcome
The age and gender matched mean total HHS for the
age and gender specific population was 94.0. The mean
HHS at time of diagnosis was 45.7 (SD, 15.1), increased
to 47.5 (SD, 15.0) (P = 0.02) at the information day.
At the 3-months follow-up visit mean HHS was 82.9
(SD, 13.1), lower than the population level (P < 0.001).
A total of 20% of the patients had a score at or above
the population level. The performance in each of the 7
items in HHS is presented inF i g u r e3 .F o rt h eg r o u p
with low (≤ 45) HHS at time of diagnosis mean HHS
was 81.1 (SD, 14.0) at follow-up, lower than population
level (P < 0.001), whereas 19% of the patients had a
score at or above the population level. For the group
with high HHS at time of diagnosis HHS was 84.3 (SD,
12.2), lower than population level (P < 0.001), whereas
23% of the patients had a score at or above the popula-
tion level.
Figure 1 Health-related quality-of-life (HRQOL) at the 4 time points for all patients and for patients with low and high preoperative
score compared to the population norm.
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follow-up mean HHS was 88.0 (SD, 15.1) (P <0 . 0 0 1 ) ,
however, 48% of the patients had a score at or above
the population level. The group with low preoperative
function had a mean HHS of 84.8 (SD, 18.1) (P <
0.001), and 41% of patients had a score at or above the
population level, whereas the group with high score pre-
operatively had a mean HHS of 89.6 (SD, 12.5) (P =
0.01), of which 51% of patients had a score at or above
the population level.
Correlation between generic and disease specific
outcomes
At 3 months postoperatively strong correlation was
observed between HRQOL measured with EQ-5 D and
disease specific score measures with HHS of 0.63. The
regression analysis revealed an association with a coeffi-
cient of 0.007 (CI, 0.005 - 0.008) (P < 0.001), where 40%
of the variance in HRQOL (R-squared) was explained by
HHS. The dichotomized items most strongly associated
with HRQOL in the final model was no or occasional
use of cane 0.09 (CI, 0.02 - 0.16) (P < 0.01), walking dis-
tance above 1.5 km 0.05 (CI, 0.01 - 0.10) (P =0 . 0 3 ) ,
being able to easily put on socks and shoes 0.06 (0.02 -
0.09) (P < 0.01), and being able to sit in all chairs 0.11
(CI, 0.08 - 0.15) (P < 0.01). In total, 39% of the variance
in PF (R-squared) was explained by these 4 items.
Likewise, 3 months postoperatively a strong correla-
tion was observed between HRQOL measured with PF
and disease specific score measures with HHS of 0.64.
The regression analysis revealed an association with a
c o e f f i c i e n to f0 . 9 2( C I ,0 . 7 4-1 . 1 1 )( P <0 . 0 0 1 ) ,w h e r e
41% of the variance in HRQOL (R-squared) was
explained by HHS. The dichotomized items most
strongly associated with PF in the final model was the
same as above no or occasional use of cane 9.7 (CI, 2.5
Figure 2 The 8 dimensions of SF36 at the 4 time points compared to the population norm and full health.
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Harris Hip Score.
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(CI, 5.9 - 19.1) (P < 0.01), being able to easily put on
socks and shoes 5.9 (0.9 - 10.9) (P = 0.02), and being
able to sit in all chairs 9.4 (CI, 3.9 - 14.8) (P <0 . 0 1 ) .I n
total, 36% of the variance in PF (R-squared) was
explained by these 4 items.
At 12 months postoperatively significant correlation
was observed between HRQOL measured with EQ-5 D
and disease specific score measures with HHS of 0.80.
The regression analysis revealed an association with a
coefficient of 0.008 (CI, 0.007 - 0.009) (P < 0.001),
where 64% of the variance in HRQOL (R-squared) was
explained by HHS. A strong correlation 12 months post-
operatively between HRQOL measured with PF and dis-
ease specific score measures with HHS of 0.70 was
observed. The regression analysis revealed an association
w i t hac o e f f i c i e n to f0 . 9 3( C I ,0 . 7 6-1 . 0 9 )( P <0 . 0 0 1 ) ,
w h e r e4 9 %o ft h ev a r i a n c ei nP F( R - s q u a r e d )w a s
explained by HHS.
Discussion
To our knowledge this is the first study to present
patient relevant long-term outcomes for patients follow-
ing fast-track THA. The study reveals that patients fol-
lowing fast-track regain health within 3-12 months
compared to an age and gender matched population
group without any formal intensive postoperative reha-
bilitation when using generic HRQOL as an outcome.
However, they do not regain health when using a dis-
ease specific outcome such as HHS.
For generic HRQOL outcome measured with EQ-5 D
the patients as a whole reached a level that was compar-
able to the age and gender matched population norm at
the 3-months follow-up, whereas they actually reached a
level that was higher than the population norm at the
12-months follow-up. Even when sub-dividing the
patients into groups with low and high preoperative
HRQOL, the patients with low preoperative HRQOL
had a non-significant lower HRQOL when compared to
the population level at 3-months follow-up.
The Swedish Hip Arthroplasty Register (SHAR) is to our
knowledge the only register, that monitor HRQOL by
using EQ-5 D as a standard [28]. Our results for mean
HRQOL of 0.90 after fast-track THA one year postopera-
tively, however, are higher than their reported average
national value of 0.76, and also higher than the hospital
with the highest average score, which was 0.86 [28]. This
difference could be attributed to selection of patients into
our fast-track intervention, but because the SHAR data
resemble our data before implementing fast-track inter-
vention [13,15,21,22] the difference in HRQOL may in our
opinion mainly be caused by the fast-track intervention.
When using SF36 and looking at the PF, the results
were somewhat different, because the patient group in
general did not reach the population level at the 3-
months follow-up. This was mostly explained by
patients with low preoperative PF who did not reach the
population norm, whereas patients with high preopera-
tive PF were not different from the population norm. At
the 12-months follow-up all patient groups had reached
the population norm. The goal for a fast-track regimen
should be to achieve the PF of the population norm as
fast as possible and with as less pain and risk of compli-
cations as possible. In a fast-track context this goal
should not be in 12 months but more likely in 3
months, and consequently we should in the future focus
on the patient group with low preoperative function
level which has the highest potential of improvement in
order to shorten convalescence before 3-months follow-
up within a fast-track context.
In contrast, by using the disease specific outcome HHS
the patients never reached a level at the population level
within one year postoperatively. This raises the principal
question if we should introduce a further rehabilitation
intervention for this patient group on the basis of generic
outcome disease specific outcome or other outcomes.
Thus, in the gender and age matched population level
the average HRQOL is not 1 (Figure 1), but reduced
from age itself and includes persons with different
chronic diseases, such as diabetes, cardiac problems,
respiratory problems, and other musculoskeletal pro-
blems that reduce the HRQOL. It is therefore question-
able if it is reasonable to take this specific THA patient
group with high HRQOL, but lacking full hip function,
and raise their disease specific health state to a level that
is at or above the age and gender specific norm at the
cost of other patient groups with much lower HRQOL.
We therefore propose that the ultimate goal after THA is
to reach a HRQOL at the population level in general,
with most focus at the pain and physical functioning
level. One way to include disease specific outcome after
fast-track THA is to set goals for the rehabilitation inter-
vention and establish clinical indicators for pain and
function so that a given proportion of patients at a given
follow-up time have to reach a given level.
We have identified a strong general correlation
between disease specific outcome and generic HRQOL
outcomes that can be used to increase HRQOL by tar-
geting those areas most strongly associated with
HRQOL, which in this population were ability to walk
without or only occasional use of cane, being able to
walk 1.5 km or longer, being able to easily put on sock
and shoes, and being able to sit comfortably in all
chairs. These areas could easily be improved by post-
operative rehabilitation.
In a fast-track context two strategies to improve
patient outcome postoperatively immerges. One strategy
is to focus on preoperative optimization of patients with
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vene with a preoperative physical optimization for this
group. The current evidence of preoperative physical
optimization is based on 4 randomized clinical trials
[29-32]. All studies demonstrated a preoperative effect
on pain and function, whereas the study by Gilmer et al.
(2003) [30] was the only study to demonstrate a signifi-
cant effect postoperatively by using a disease specific
outcome. However, none of these studies were per-
formed within the concept of fast-track surgery. The
second strategy is to focus on early postoperative reha-
bilitation on those with specific problems, and intervene
with a rehabilitation that can address these problems.
However, the postoperative period is less feasible
because postoperative mobilization restrictions hinder
early and active rehabilitation. In our study, we used a
conservative 3 months postoperative hip restriction per-
iod, which is a problem in fast-track because the restric-
tions interfere with recovery [33]. No consensus exists
of postoperative hip restrictions, but the scarce existing
evidence spreads from no restrictions to 6 weeks restric-
tions with no more than 90° of hip flexion, no adduction
past neutral, and no internal rotation past neutral [33].
If the postoperative restriction could be omitted or
strongly modified there is a great potential for early and
aggressive rehabilitation intervention [34]. Another argu-
ment for being less restrictive postoperatively is the shift
towards greater implant heads, which is thought to
reduce the risk of dislocation.
In our follow-up period we had a total loss to follow-
up of 5%, 15% at the 3-months follow-up and 23% at
the 12 months follow-up. This proportion of loss to fol-
low-up is normal in studies of this kind [23], but still a
problem because loss to follow-up has been shown to
be associated with both poorer or no difference in out-
come [35,36]. We did, however, not observe any differ-
ence in the collected baseline variables between the
patients who were followed up and the patients who
were lost to follow-up and therefore consider our results
to be unbiased and representative for the entire sample.
Another problem which has to be taken into account
is the population norm scores we have used as controls.
The data concerning EQ-5 D were obtained from three
recent large Danish population studies including almost
26.000 persons providing very reliable data for compari-
son, but for SF36 the data were from 3950 persons and
from 1994 [37,38] This is a possible flaw when compar-
ing our results from 2007. However, until new and
more precise population norm data are presented we
believe that the SF-36 used population norm data is
adequate and useful. For HHS no normative data exist
f r o mD e n m a r k ,a n dw eu s e dd a t af r o mas t u d yf r o m
California including only 184 persons aged 55 or more
as controls, which also may give a flaw in our analysis.
Although we did create a rather homogeneous case
mix for study purpose, we still believe that our observed
results will apply for the most and average THA patients
irrespective of age, gender and diagnosis.
Conclusions
If HRQOL is considered the primary outcome after
THA, the need for additional postoperative rehabilita-
tion for all THA patients following a fast-track interven-
tion is questionable. However, a pre- or early
postoperative physical intervention seems relevant if the
PF of the population norm should be reached at 3
months especially for those with low pre-operative func-
tions, and this should be the goal for a fast-track regi-
men more than to reach the PF of the population norm
after 12 months. If disease specific outcome is consid-
ered the primary outcome after fast-track THA, clear
goals for the rehabilitation must be established before
patient selection, intervention type and timing of inter-
vention can be made.
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